NSABP Members' Area   Password Protected - Access   Limited to NSABP Participating   Institutions Only NSABP Foundation, Inc. General NSABP Information   Contact the NSABP   Pathology Section   Future Meetings   NSABP Newsletters   Media Info on cMYC Study   Media Info on STAR   Employment Clinical Trials Information   Clinical Trials Overview   Protocol Chart   Never Say Lost Treatment Trials Information   Protocol B-36   Protocol B-37   Protocol B-39   Protocol B-40   Protocol B-41   Protocol B-42   Protocol C-10   Protocol R-04 Prevention Trials Information   Protocol P-1 - BCPT   Protocol P-2 - STAR   BreastCancerPrevention.com Bibliography of Publications Related Web Sites About the NSABP Web Site Helper Applications Links to Major Search Engines Medical Search Engines To report problems, ask questions or make comments, please send e-mail to: Webmaster@nsabp.pitt.edu

NSABP Clinical Trials Overview Protocol P-2 (STAR) The Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer Specific Aims This study will determine if raloxifene is either more or less effective than tamoxifen in reducing the incidence of invasive breast cancer in postmenopausal women who are at increased risk for the disease. A secondary goal is to determine whether raloxifene reduces the endometrial cancer rate compared to tamoxifen.